Publications

  1. Lee RJ, Tzou KS, Heckman MG, Hobbs CJ, Rawal B, Diehl NN, Peterson JL, Paryani NN, Ko SJ, Daugherty LC, Vallow LA, Wong W, Schild S, Pisansky TM, Buskirk SJ. Proposed prognostic scoring system evaluating risk factors for biochemical recurrence of prostate cancer after salvage radiation therapy. BJU Int. 2015 Jul 18.
    View PubMed
  2. Liu X, Fatyga M, Li J, Schild M, Schild S, Vora S, Wong W, Wu T. TH-AB-304-02: Fitting Grade>=2(2+) Acute Rectal Complication Rates in Prostate Cancer Patients to Lyman Kutcher Burman (LKB) and Logistic Regression NTCP Models Using Dosimetry and Patient Specific Characteristics. Med Phys. 2015 Jun; 42(6):3700.
    View PubMed
  3. Shin J, Liang J, Schild S, Wong W, Liu W. SU-E-T-349: Effective Dose-Volume-Histogram Prediction Method Using Euclidean Distance Volume Histogram for Volumetric Modulated Arc Therapy to Treat Prostate Cancer. Med Phys. 2015 Jun; 42(6):3413.
    View PubMed
  4. Hu Y, James J, Panda A, Vargas C, Silva A, Liu W, Shen J, Ding X, Paden R, Hanson J, Wong W, Schild S, Bues M. SU-E-J-229: Magnetic Resonance Imaging of Small Fiducial Markers for Proton Beam Therapy. Med Phys. 2015 Jun; 42(6):3318.
    View PubMed
  5. Liu W, Patel S, Shen J, Harrington D, Stoker J, Ding X, Hu Y, Wong W, Halyard M, Schild S, Ezzell G, Bues M. SU-E-T-618: Plan Robustness Study of Volumetric-Modulated Arc Therapy Vs. Intensity-Modulated Radiation Therapy for Head and Neck Cancer. Med Phys. 2015 Jun; 42(6):3478.
    View PubMed
  6. Liu W, Schild S, Chang J, Liao Z, Wen Z, Shen J, Stoker J, Wong W, Sahoo N, Herman M, Mohan R, Bues M. SU-F-BRD-01: A Novel 4D Robust Optimization Mitigates Interplay Effect in Intensity-Modulated Proton Therapy for Lung Cancer. Med Phys. 2015 Jun; 42(6):3525.
    View PubMed
  7. Fatyga M, Schild S, Vora S, Schild M, Wong W, Liu X, Li J, Wu T. SU-E-T-803: Verification of QUANTEC Lyman Kutcher Burman (LKB) Model for Grade>=2(2+) Late Rectal Complication Rates Using a Database of 79 Prostate Patients Treated with IMRT. Med Phys. 2015 Jun; 42(6):3522.
    View PubMed
  8. Parikh P, Pockaj B, Wasif N, Halyard M, Wong W, Kosiorek HE, Dueck AC, Gray R. Multidisciplinary Shared Decision Making in the Management of Ductal Carcinoma In Situ of the Breast. Ann Surg Oncol. 2015 May 19.
    View PubMed
  9. Patel SH, Hayden RE, Hinni ML, Wong WW, Foote RL, Milani S, Wu Q, Ko SJ, Halyard MY. Angiosarcoma of the scalp and face: the Mayo Clinic experience. JAMA Otolaryngol Head Neck Surg. 2015 Apr; 141(4):335-40.
    View PubMed
  10. Liu W, Liao Z, Schild SE, Liu Z, Li H, Li Y, Park PC, Li X, Stoker J, Shen J, Keole S, Anand A, Fatyga M, Dong L, Sahoo N, Vora S, Wong W, Zhu XR, Bues M, Mohan R. Impact of respiratory motion on worst-case scenario optimized intensity modulated proton therapy for lung cancers. Pract Radiat Oncol. 2015 Mar-Apr; 5(2):e77-86. Epub 2014 Sep 11.
    View PubMed
  11. Dirksen SR, Belyea MJ, Wong W, Epstein DR. Transitions in Symptom Cluster Subgroups Among Men Undergoing Prostate Cancer Radiation Therapy. Cancer Nurs. 2015 Feb 27.
    View PubMed
  12. Ho TH, Nateras RN, Yan H, Park JG, Jensen S, Borges C, Lee JH, Champion MD, Tibes R, Bryce AH, Carballido EM, Todd MA, Joseph RW, Wong WW, Parker AS, Stanton ML, Castle EP. A Multidisciplinary Biospecimen Bank of Renal Cell Carcinomas Compatible with Discovery Platforms at Mayo Clinic, Scottsdale, Arizona. PLoS One. 2015; 10(7):e0132831. Epub 2015 Jul 16.
    View PubMed
  13. Schild MH, Schild SE, Wong WW, Vora SA, Silva AC, Silva AM, Daniels TB, Keole SR. Early Outcome of Prostate Intensity Modulated Radiation Therapy (IMRT) Incorporating a Simultaneous Intra-Prostatic MRI Directed Boost. OMICS J Radiol. 2014 Dec; 3(4).
    View PubMed
  14. Schild MH, Wong WW, Valdez R, Leis JF. Primary pulmonary classical Hodgkin lymphoma: a case report. J Surg Oncol. 2014 Sep; 110(3):341-4. Epub 2014 Apr 29.
    View PubMed
  15. Patel SH, Wang Z, Wong WW, Murad MH, Buckey CR, Mohammed K, Alahdab F, Altayar O, Nabhan M, Schild SE, Foote RL. Charged particle therapy versus photon therapy for paranasal sinus and nasal cavity malignant diseases: a systematic review and meta-analysis. Lancet Oncol. 2014 Aug; 15(9):1027-38. Epub 2014 Jun 26.
    View PubMed
  16. Paly JJ, Hallemeier CL, Biggs PJ, Niemierko A, Roeder F, Martinez-Monge R, Whitson J, Calvo FA, Fastner G, Sedlmayer F, Wong WW, Ellis RJ, Haddock MG, Choo R, Shipley WU, Zietman AL, Efstathiou JA. Outcomes in a multi-institutional cohort of patients treated with intraoperative radiation therapy for advanced or recurrent renal cell carcinoma. Int J Radiat Oncol Biol Phys. 2014 Mar 1; 88(3):618-23. Epub 2014 Jan 8
    View PubMed
  17. Wong WW, Pockaj BA, Vora SA, Halyard MY, Gray RJ, Schild SE. Six-year outcome of a prospective study evaluating tumor bed boost with intra-operative electron irradiation followed by whole-breast irradiation for early-stage breast cancer. Breast J. 2014 Mar-Apr; 20(2):125-30. Epub 2013 Dec 26.
    View PubMed
  18. Patel SH, Hinni ML, Hayden RE, Wong WW, Dueck AC, Zarka MA, Curtis KK, Halyard MY. Transoral laser microsurgery followed by radiation therapy for oropharyngeal tumors: the Mayo Clinic Arizona experience. Head Neck. 2014 Feb; 36(2):220-5. Epub 2013 Mar 26.
    View PubMed
  19. Wisenbaugh ES, Andrews PE, Ferrigni RG, Schild SE, Keole SR, Wong WW, Vora SA. Proton beam therapy for localized prostate cancer 101: basics, controversies, and facts. Rev Urol. 2014; 16(2):67-75.
    View PubMed
  20. Vora SA, Wong WW, Schild SE, Ezzell GA, Andrews PE, Ferrigni RG, Swanson SK. Outcome and toxicity for patients treated with intensity modulated radiation therapy for localized prostate cancer. J Urol. 2013 Aug; 190(2):521-6. Epub 2013 Feb 13.
    View PubMed
  21. Wong WW, Schild SE, Vora SA, Ezzell GA, Nguyen BD, Ram PC, Roarke MC. Image-guided radiotherapy for prostate cancer: a prospective trial of concomitant boost using indium-111-capromab pendetide (ProstaScint) imaging. Int J Radiat Oncol Biol Phys. 2011 Nov 15; 81(4):e423-9. Epub 2011 Apr 07.
    View PubMed
  22. Wong NW, Wong WW, Karlin NJ, Gray RJ. Radiation recall secondary to adjuvant docetaxel after balloon-catheter based accelerated partial breast irradiation. Radiography. 2010; 16(3):253-5 Epub 2010 Apr 28.
    View PubMed
  23. Wong WW, Vora SA, Schild SE, Ezzell GA, Andrews PE, Ferrigni RG, Swanson SK. Radiation dose escalation for localized prostate cancer: intensity-modulated radiotherapy versus permanent transperineal brachytherapy. Cancer. 2009 Dec 1; 115(23):5596-606.
    View PubMed
  24. Nguyen BD, Schild SE, Wong WW, Vora SA. Prostate brachytherapy seed embolization to the right renal artery. Brachytherapy. 2009 Jul-Sep; 8(3):309-12. Epub 2009 Feb 12.
    View PubMed
  25. Schild MH, Wong WW, Vora SA, Ward LD, Nguyen BD. Embolization of an iodine-125 radioactive seed from the prostate gland into the right ventricle: An unusual pattern of seed migration. Radiography. 2009; 15(2):179-81.
    View PubMed
  26. Vora SA, Wong WW, Schild SE, Ezzell GA, Halyard MY. Analysis of biochemical control and prognostic factors in patients treated with either low-dose three-dimensional conformal radiation therapy or high-dose intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2007 Jul 15; 68(4):1053-8. Epub 2007 Mar 29.
    View PubMed
  27. Wong WW, Buskirk SJ, Schild SE, Prussak KA, Davis BJ. Combined prostate brachytherapy and short-term androgen deprivation therapy as salvage therapy for locally recurrent prostate cancer after external beam irradiation. J Urol. 2006 Nov; 176(5):2020-4.
    View PubMed
  28. Lyons MK, Drazkowski JF, Wong WW, Fitch TR, Nelson KD. Metastatic prostate carcinoma mimicking meningioma: case report and review of the literature. Neurologist. 2006 Jan; 12(1):48-52.
    View PubMed
  29. Schild SE, Wong WW, Vora SA, Halyard MY, Northfelt DW, Kogut HL, Wheeler RH. The long-term results of a pilot study of three times a day radiotherapy and escalating doses of daily cisplatin for locally advanced non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2005 Aug 1; 62(5):1432-7.
    View PubMed
  30. Schwartz DJ, Schild SE, Wong WW, Vora SA. Factors associated with the frequency of self-intermittent catheterization after prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2005 Jan 1; 61(1):60-3.
    View PubMed
  31. Drazkowski JF, Fitch TR, Lyons MK, Nelson KD, Wong WW. Metastatic prostate carcinoma mimicking meningioma. African Journal of Neurological Sciences. 2005; 24(2):96-100.
    View PubMed
  32. MacDonald OK, Schild SE, Vora S, Andrews PE, Ferrigni RG, Novicki DE, Swanson SK, Wong WW. Salvage radiotherapy for men with isolated rising PSA or locally palpable recurrence after radical prostatectomy: do outcomes differ? Urology. 2004 Oct; 64(4):760-4.
    View PubMed
  33. Wong WW, Schild SE, Vora SA, Halyard MY. Association of percent positive prostate biopsies and perineural invasion with biochemical outcome after external beam radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2004 Sep 1; 60(1):24-9.
    View PubMed
  34. Schild SE, Korte SM, Wong WW, Vora SA, Younggren JA, Ezzell GA. Treatment planning for dose escalation in non-small cell lung cancer (NSCLC). Med Dosim. 2004 Fall; 29(3):196-203.
    View PubMed
  35. Halyard MY, McCombs KE, Wong WW, Buchel EW, Pockaj BA, Vora SA, Gray RJ, Schild SE. Acute and chronic results of adjuvant radiotherapy after mastectomy and Transverse Rectus Abdominis Myocutaneous (TRAM) flap reconstruction for breast cancer. Am J Clin Oncol. 2004 Aug; 27(4):389-94.
    View PubMed
  36. Macdonald OK, Schild SE, Vora SA, Andrews PE, Ferrigni RG, Novicki DE, Swanson SK, Wong WW. Salvage radiotherapy for palpable, locally recurrent prostate cancer after radical prostatectomy. Int J Radiat Oncol Biol Phys. 2004 Apr 1; 58(5):1530-5.
    View PubMed
  37. Macdonald OK, Schild SE, Vora SA, Andrews PE, Ferrigni RG, Novicki DE, Swanson SK, Wong WW. Radiotherapy for men with isolated increase in serum prostate specific antigen after radical prostatectomy. J Urol. 2003 Nov; 170(5):1833-7.
    View PubMed
  38. Schild SE, Wong WW, Vora SA, Halyard MY, Wheeler RH. Phase I study of hyperfractionated accelerated radiotherapy and escalating doses of daily cisplatin for patients with locally advanced non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2002 Nov 1; 54(3):729-34.
    View PubMed
  39. Wong WW, Schild SE, Halyard MY, Schomberg PJ. Primary non-Hodgkin lymphoma of the breast: The Mayo Clinic Experience. J Surg Oncol. 2002 May; 80(1):19-25; discussion 26.
    View PubMed
  40. Ezzell GA, Schild SE, Wong WW. Development of a treatment planning protocol for prostate treatments using intensity modulated radiotherapy. J Appl Clin Med Phys. 2001 Spring; 2(2):59-68.
    View PubMed
  41. Schild SE, Nisi K, Scheithauer BW, Wong WW, Lyons MK, Schomberg PJ, Shaw EG. The results of radiotherapy for ependymomas: the Mayo Clinic experience. Int J Radiat Oncol Biol Phys. 1998 Dec 1; 42(5):953-8.
    View PubMed
  42. Schild SE, Stafford SL, Brown PD, Wood CP, Scheithauer BW, Schomberg PJ, Wong WW, Lyons MK, Shaw EG. The results of radiotherapy for brainstem tumors. J Neurooncol. 1998 Nov; 40(2):171-7.
    View PubMed
  43. Wong WW, Hirose T, Scheithauer BW, Schild SE, Gunderson LL. Malignant peripheral nerve sheath tumor: analysis of treatment outcome. Int J Radiat Oncol Biol Phys. 1998 Sep 1; 42(2):351-60.
    View PubMed
  44. Schild SE, Wong W. The role of retrograde urethrography in the planning of prostate cancer radiotherapy. Med Dosim. 1997 Summer; 22(2):83-6.
  45. Schild SE, Scheithauer BW, Haddock MG, Schiff D, Burger PC, Wong WW, Lyons MK. Central neurocytomas. Cancer. 1997 Feb 15; 79(4):790-5.
    View PubMed
  46. Schild SE, Gunderson LL, Haddock MG, Wong WW, Nelson H. The treatment of locally advanced colon cancer. Int J Radiat Oncol Biol Phys. 1997 Jan 1; 37(1):51-8.
    View PubMed
  47. Schild SE, Scheithauer BW, Haddock MG, Wong WW, Lyons MK, Marks LB, Norman MG, Burger PC. Histologically confirmed pineal tumors and other germ cell tumors of the brain. Cancer. 1996 Dec 15; 78(12):2564-71.
    View PubMed
  48. Schild SE, Buskirk SJ, Wong WW, Halyard MY, Swanson SK, Novicki DE, Ferrigni RG. The use of radiotherapy for patients with isolated elevation of serum prostate specific antigen following radical prostatectomy. J Urol. 1996 Nov; 156(5):1725-9.
    View PubMed
  49. Schild SE, Haddock MG, Scheithauer BW, Marks LB, Norman MG, Burger PC, Wong WW, Lyons MK, Schomberg PJ. Nongerminomatous germ cell tumors of the brain. Int J Radiat Oncol Biol Phys. 1996 Oct 1; 36(3):557-63.
    View PubMed
  50. Schild SE, Wong WW, Novicki DE, Ferrigni RG, Swanson SK. Detection of residual prostate cancer after radical prostatectomy with the Abbott IMx PSA assay. Urology. 1996 Jun; 47(6):878-81.
    View PubMed
  51. Wong WW, Schild SE, Sawyer TE, Shaw EG. Analysis of outcome in patients reirradiated for brain metastases. Int J Radiat Oncol Biol Phys. 1996 Feb 1; 34(3):585-90.
    View PubMed
  52. Schild SE, Wong WW, Grado GL, Halyard MY, Novicki DE, Swanson SK, Larson TR, Ferrigni RG. The result of radical retropubic prostatectomy and adjuvant therapy for pathologic stage C prostate cancer. Int J Radiat Oncol Biol Phys. 1996 Feb 1; 34(3):535-41.
    View PubMed
  53. Wong WW, Schild SE, Martenson JA. Role of radiation therapy and fluoropyrimidines in the treatment of gastrointestinal malignancies. Cancer Control. 1996; 3(4):319-328.
    View PubMed
  54. Mundt AJ, Awan A, Sibley GS, Simon M, Rubin SJ, Samuels B, Wong W, Beckett M, Vijayakumar S, Weichselbaum RR. Conservative Surgery and Adjuvant Irradiation in the Management of Adult Soft Tissue Sarcoma: Clinical and Radiobiological Results. Int J RadiatOncolBiol Phys. 1995; 32:977-986.
  55. Schild SE, Wong WW, Grado GL, Buskirk SJ, Ferrigni RL. The Use of Radiotherapy for Patients with Isolated Elevation of Serum PSA Levels following Radical Prostatectomy. Radiology. 1995; 294:293.
  56. Wong WW, Pluth JR, Grado GL, Schild SE, Sanderson DR. Liposarcoma of the pleura. Mayo Clin Proc. 1994 Sep; 69(9):882-5.
    View PubMed
  57. Schild SE, Wong WW, Grado GL, Buskirk SJ, Robinow JS, Frick LM, Ferrigni RG. Radiotherapy for isolated increases in serum prostate-specific antigen levels after radical prostatectomy. Mayo Clin Proc. 1994 Jul; 69(7):613-9.
    View PubMed
  58. Wong WW, Mick R, Haraf D, Weichselbaum R, Vokes E. Time-dose Analysis for Local Tumor Control Following Alternate Week Concomitant Radiation and Chemotherapy of Advanced Head and Neck Cancer. Int J Radiat Oncol Biol Phys. 1994; 29:153-162.
    View PubMed
  59. Wong WW, Vijayakumar S, Weichselbaum RR. Prognostic indicators in node-negative early stage breast cancer. Am J Med. 1992 May; 92(5):539-48.
    View PubMed
  60. Wong WW, Chen G. OTCs and the pregnant woman. How hazardous? Mod Med. 1983 Jan; 51:223-225.